))
ADHD Medications: Risk, Bias, and Real Outcomes
Manage episode 493636461 series 3676728
Content provided by James Kennedy, PMHNP-BC & Jon Murphy, PMHNP-BC and Compass Point Institute. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by James Kennedy, PMHNP-BC & Jon Murphy, PMHNP-BC and Compass Point Institute or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Title: ADHD Medications: Risk, Bias, and Real Outcomes
Hosts: James Kennedy, PMHNP-BC & Jon Murphy, PMHNP-BC
In this first episode of Compass Point Institute, James and Jon break down a major new study published in JAMA Psychiatry (June 25, 2025) tracking ADHD medication outcomes in over 260,000 individuals.
🎯 Topics covered:
- Key findings from a 15-year longitudinal study
- Reduced self-harm, accident, and criminal risk
- Navigating stigma, DEA scrutiny, and Schedule II status
- Provider bias and the myth of “weekend breaks”
- Practical clinical guidance on stimulant prescribing
- The difference between physiological vs psychological addiction
This episode is designed to support mental health clinicians with real-world data, clear context, and grounded insight.
📬 Have a topic you want us to cover? Reach out anytime.
🧭 Compass Point Institute — Empowering the next generation of mental health clinicians.
One episode
Share
